Trimethylamine N-Oxide (TMAO) and Metabolic Disorders: A New Biomarker in Health

Trimethylamine-N-Oxide (TMAO) is a compound that has garnered significant attention in recent years due to its emerging role in metabolic health and disease. TMAO is produced in the liver from trimethylamine (TMA), which is primarily generated by gut microbiota from dietary sources rich in choline and carnitine, such as red meat, eggs, and certain dairy products. Understanding the biochemical pathways leading to the formation of TMAO is crucial for health practitioners, dietitians, and researchers, as it may provide insights into its potential implications for cardiovascular health and other metabolic disorders.